BioLine Launches New Products For Epigenetics Research
2/18/2014 8:16:36 AM
CINCINNATI--(BUSINESS WIRE)--Bioline, The PCR Company, a wholly-owned subsidiary of Meridian Bioscience, Inc. (NASDAQ:VIVO), announces that it has entered the rapidly growing Epigenetics field, with the launch of the first kits in the new EPIK™ product range; EPIK™ Fast Quantification Kit and EPIK™ Amplification Kit.
Help employers find you! Check out all the jobs and post your resume.
comments powered by